| # | Drug | Count |
|---|---|---|
| 0 | ARIPIPRAZOLE | 32 |
| 1 | ARIPIPRAZOLE ORAL | 27 |
| 2 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 27 |
| 3 | RISPERIDONE | 7 |
| 4 | FLUOXETINE | 4 |
| 5 | FLUOXETINE HYDROCHLORIDE | 4 |
| 6 | LORAZEPAM | 4 |
| 7 | LURASIDONE HYDROCHLORIDE | 3 |
| 8 | DIMENHYDRINATE | 2 |
| 9 | METHADONE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ARIPIPRAZOLE | 32 | 0.0003 |
| 1 | CABERGOLINE | 1 | 0.0002 |
| 2 | DIMENHYDRINATE | 2 | 0.0002 |
| 3 | LURASIDONE HYDROCHLORIDE | 3 | 0.0001 |
| 4 | LANREOTIDE ACETATE | 1 | 0.0001 |
| 5 | VILAZODONE HYDROCHLORIDE | 1 | 0.0001 |
| 6 | RISPERIDONE | 7 | 0.0001 |
| 7 | METHADONE | 2 | 0.0000 |
| 8 | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | 1 | 0.0000 |
| 9 | TESTOSTERONE | 1 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 32 |
| 1 | Benzodiazepine [EPC] | 4 |
| 2 | Corticosteroid [EPC] | 2 |
| 3 | Vitamin C [EPC] | 2 |
| 4 | Androgen [EPC] | 1 |
| 5 | CTLA-4-directed Blocking Antibody [EPC] | 1 |
| 6 | Ergot Derivative [EPC] | 1 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 1 |
| 8 | Interferon beta [EPC] | 1 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 1 | Atypical Antipsychotic [EPC] | 32 | 0.0001 |
| 2 | Androgen [EPC] | 1 | 0.0000 |
| 3 | CTLA-4-directed Blocking Antibody [EPC] | 1 | 0.0000 |
| 4 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 1 | 0.0000 |
| 5 | Benzodiazepine [EPC] | 4 | 0.0000 |
| 6 | Interferon beta [EPC] | 1 | 0.0000 |
| 7 | Vitamin C [EPC] | 2 | 0.0000 |
| 8 | Vitamin D [EPC] | 1 | 0.0000 |
| 9 | Vitamin B12 [EPC] | 1 | 0.0000 |